Maja Ercegovac

Introduction. Invasive pulmonary mucormycosis is one of the most severe and potentially fatal fungal infections in immunocompromised patients, particularly in recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Diagnosis and treatment of pulmonary mucormycosis remain challenging. Case outline. We present a 19-year-old male patient with relapsed acute myeloid leukemia (AML) following allo-HSCT whose treatment was complicated by proven pulmonary mucormycosis. The infection was managed using an integrated medical and surgical approach, including liposomal amphotericin B with dose escalation, prolonged treatment with oral isavuconazole, and right lower lobectomy. Postoperatively, the patient developed Pseudomonas aeruginosa sepsis and pneumothorax requiring drainage; both complications were successfully managed. Subsequent computed tomography (CT) scans demonstrated regression and complete radiological resolution of the pulmonary lesion. Conclusion. This case illustrates the complexity of managing pulmonary mucormycosis in a severely immuno-compromised patient with relapsed AML after allo-HSCT and concomitant graft-versus-host disease (GVHD). Successful management required a multidisciplinary approach combining antifungal therapy and thoracic surgery, followed by prolonged antifungal treatment and close radiological monitoring.

Background: Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for the majority of cases. Radiomics and artificial intelligence (AI) have emerged as promising tools for quantitative imaging analysis and precision staging. This study aimed to evaluate the ability of an AI-based radiomics model to preoperatively predict tumor (T) and nodal (N) stage, lymphovascular invasion (LVI), and postoperative complications in patients with early-stage NSCLC. Material and Methods: This retrospective study included 51 consecutive patients who underwent anatomical lobectomy with systematic lymph node dissection between 2019 and 2024, at the Clinic for Thoracic Surgery of the University Clinical Center of Serbia. Quantitative imaging features were extracted from preoperative CT scans using the Lesion Scout with Auto ID module (syngo.via VB50 MM, Siemens Healthineers). Radiomics and clinical predictors were analyzed using regularized logistic regression (LASSO) with five-fold cross-validation. Model performance was assessed using AUC, accuracy, sensitivity, specificity, precision, and F1 score, and calibration was evaluated using the Hosmer–Lemeshow test. Groups were compared using parametric and non-parametric tests. Correlation between the variables was assessed using Spearman’s rank correlation coefficient. All p-values less than 0.05 were considered significant. Results: The AI-based model showed excellent performance for predicting the T component (training AUC = 0.89; test AUC = 0.86; F1 = 0.81) and acceptable calibration (p = 0.41). Nodal metastasis (OR = 0.108; 95% CI: 0.011–1.069; p = 0.057) and LVI (OR = 0.519; 95% CI: 0.139–1.937; p = 0.329) were not significantly predicted. Emphysema was identified as a significant independent predictor of postoperative complications (χ² = 5.13; p = 0.024). Conclusions: The AI-driven radiomics model demonstrated strong predictive ability for the T component and identified emphysema as a clinically relevant predictor of postoperative complications.

Background and Objectives: Lung cancer is the second most common form of cancer in the world for both men and women as well as the most common cause of cancer-related deaths worldwide. The aim of this study is to summarize the radiological characteristics between primary lung adenocarcinoma subtypes and to correlate them with FDG uptake on PET-CT. Materials and Methods: This retrospective study included 102 patients with pathohistologically confirmed lung adenocarcinoma. A PET-CT examination was performed on some of the patients and the values of SUVmax were also correlated with the histological and morphological characteristics of the masses in the lungs. Results: The results of this analysis showed that the mean size of AIS-MIA (adenocarcinoma in situ and minimally invasive adenocarcinoma) cancer was significantly lower than for all other cancer types, while the mean size of the acinar cancer was smaller than in the solid type of cancer. Metastases were significantly more frequent in solid adenocarcinoma than in acinar, lepidic, and AIS-MIA cancer subtypes. The maximum standardized FDG uptake was significantly lower in AIS-MIA than in all other cancer types and in the acinar predominant subtype compared to solid cancer. Papillary predominant adenocarcinoma had higher odds of developing contralateral lymph node involvement compared to other types. Solid adenocarcinoma was associated with higher odds of having metastases and with higher SUVmax. AIS-MIA was associated with lower odds of one unit increase in tumor size and ipsilateral lymph node involvement. Conclusions: The correlation between histopathological and radiological findings is crucial for accurate diagnosis and staging. By integrating both sets of data, clinicians can enhance diagnostic accuracy and determine the optimal treatment plan.

Traditional chemotherapy is the standard of care for lung squamous cell carcinoma (LSCC). However, recent studies have suggested that precision medicine platforms could help identify better treatment options. Our approach involves testing various chemotherapeutics in cells isolated from LSCC patients’ biopsies to make more informed treatment decisions. Five primary LSCC cultures from patient-derived cells were established and exposed to 8 different chemotherapeutics and erlotinib 72 h after culturing, with treatments lasting for 7 days. An immunofluorescence assay with a CK8/18 antibody mixture was utilized to distinguish cancer cells from stromal cells, while a scoring method involving 11 weighted parameters was applied to calculate the drug response score for LSCC patients’ cell responses. Our results suggest that erlotinib could be an effective treatment for LSCC patients and that the dosage of erlotinib might be reduced without compromising its effectiveness. Our findings show that gemcitabine, in addition to platinum drugs, could be beneficial for LSCC patients. The results underscore the potential of functional screening methods to identify effective treatments for LSCC.

Lung cancer remains the leading cause of cancer death globally, with non-small cell lung cancer (NSCLC) accounting for the majority of cases. Multidrug resistance (MDR), often caused by ATP-binding cassette (ABC) transporters, represents a significant obstacle in the treatment of NSCLC. While genetic profiling has an important role in personalized therapy, functional assays that measure cellular responses to drugs are gaining in importance. We developed an automated microplate-based immunofluorescence assay for the evaluation of MDR markers ABCB1, ABCC1, and ABCG2 in cells obtained from NSCLC patients through high-content imaging and image analysis, as part of a functional diagnostic approach. This assay effectively discriminated cancer from non-cancer cells within mixed cultures, which is vital for accurate assessment of changes in MDR marker expression in different cell populations in response to anticancer drugs. Validation was performed using established drug-sensitive (NCI-H460) and drug-resistant (NCI-H460/R) NSCLC cell lines, demonstrating the assay’s capacity to distinguish and evaluate different MDR profiles. The obtained results revealed wide-ranging effects of various chemotherapeutic agents on MDR marker expression in different patient-derived NSCLC cultures, emphasizing the need for MDR diagnostics in NSCLC. In addition to being a valuable tool for assessing drug effects on MDR markers in different cell populations, the assay can complement genetic profiling to optimize treatment. Further assay adaptations may extend its application to other cancer types, improving treatment efficacy while minimizing the development of resistance.

The pattern and factors influencing the lung function recovery in the first postoperative days are still not fully elucidated, especially in patients at increased risk.

Beside the well known predominance of distant vs. loco-regional relapse, several aspects of the relapse pattern still have not been fully elucidated.

Nontraumatic subcutaneous emphysema is less frequent than traumatic. Its occurrence, unless synchronous with the treatment of spontaneous pneumothorax, usually is the consequence of exacerbation of COPD or of the obstruction of major bronchi. However, in routine clinical practice, the occurrence of subcutaneous emphysema without evident underlying disease, in combination with normal chest x-ray, still is a diagnostic and therapeutic problem. In this study typical mechanisms of this phenomenon are presented; air-trapping at the level of the main bronchus caused by endobronchial tumour growth, progressive destruction of alveoles by diffuse lung disease irrespective of its nature, and mechanism of its occurrence during dealing with the urgent clinical problem in the intensive care unit. This study does not deal with subcutaneous emphysema during the attack of severe asthma assuming it as well known situation that usually does not cause a major therapeutic problem. The sequence of necessary diagnostic and therapeutic steps is discussed taking account of possible pitfalls that usually exist in all of three described pathophysiological situations.

Influence of performed diagnostic and therapeutic procedures on the outcome of the treatment of traumatic hemopneumothorax during isolated chest trauma. The aim of this study is the assessment of the influence of performed diagnostic and therapeutic procedures on the outcome of hemopneumothorax as a part of isolated chest trauma. The main group consists of 51 patients with hemopneumothorax. Patients with pneumothorax without effusion represent the first control group; the second control group consist of patients treated because of iatrogenic pneumothorax. In the main and control groups the analysis of clinical, roentgenographic and functional parameters was made, together with the analysis of particular therapeutic procedures, the estimation of the success of the treatment was based on roentgenographic and functional parameters. The higher incidence of hemopneumothorax compared with control groups during chest trauma in the analyzed material is statistically significant. The occurrence of bilateral hemopneumothorax in 10% of cases emphasizes the need of adequate roentgenographic assessment of injured patients. Regardless of the intensity of the trauma, symptoms do not always indicate the existence of hemopneumothorax. The number of fractured ribs is not of significant importance in terms of the occurrence of hemopneumothorax or pneumothorax. Severe dyspnea can be accompanied even with a smaller collapse of the lung independently of the amount of blood in the pleural cavity. Oxygenation in the arterial blood is impaired with the great and small pulmonary collapse. Hemodynamic disorders existed in 14% all cases. The higher frequency of operative treatment in the main group is statistically significant. The majority of cases of traumatic hemopneumothorax can be successfully treated by the conservative treatment. Accompanying complications do not have greater influence on the outcome.